Women's Health Initiative - BioInnovation Institute

Women’s Health Initiative

About the initiative

BII’s Women’s Health Initiative aims to strengthen the European ecosystem for innovative translational research and start-ups that address the high medical unmet needs within women’s health.

Parts of the Women’s Health Initiative activities are supported by a grant from Bill & Melinda Gates Foundation.

As part of this joint initiative, BII will conduct a thorough landscape analysis and identify leading research and start-up opportunities for women’s health, with the potential for future funding from BII and partners.

BII will also undertake community-building and awareness-creating activities with selected key partners within the ecosystem.

Please contact Johanna Roostalu at e-mail: jro@bii.dk if you have any questions.

Our focus areas

BII aims to support women’s health across a broad range of indication areas. We are especially interested in new non-hormonal therapeutics solutions, and evidence-based health tech approaches. For specifics, please click on the images below.

Our Bio Studio program welcomes innovative projects that focus on developing new transformative therapeutics or health tech solutions to address high unmet medical needs in women’s health.

Our Programs

Our programs

Bio Studio
Establishes spin-out companies based on transformative research
Venture Lab
Helps start-ups in the early phases
Venture House
Matures projects to attract substantial funding
Deep Tech Lab - Quantum
Supports early-stage quantum technology startups
Women's Health Innovation Panel

Below you can read all the news related to BII’s Women’s Health Initiative.

Supported start-up companies and projects

Meet our Women’s Health Team
About BII

The BioInnovation Institute Foundation (BII) is an international commercial foundation with a nonprofit objective supported by the Novo Nordisk Foundation. BII operates an incubator to accelerate world-class life science innovation that drives the development of new solutions by early life science start-ups for the benefit of people and society.

BII, located in Copenhagen, Denmark, offers start-ups and early-stage projects within health tech, therapeutics, and bioindustrials state-of-the-art labs, vibrant office facilities, business development, start-up business incubation, access to high-level mentoring and international networks, plus unique funding opportunities of up to 1.7 million euros per start-up and 3 million euros per project.

Since the inauguration of BII in November 2018, BII has awarded 71 million euros to 80 high-growth start-up companies.